MedPath

Study of 123I-Iomazenil SPECT for neurobehavioral deficits after traumatic brain injury

Not Applicable
Conditions
neurobehavioral deficits after traumatic brain injury
Registration Number
JPRN-UMIN000008095
Lead Sponsor
IMZ-TBI Executive Committee
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Those who need to continue Benzodiazepines without interruption for 1 week. Those who perform neuropsychological tests. Those who have a history of mental or neurologiocal disorders before the brain injury. Those in whom PTSD were strongly suspected. Those with hypopituitarism. Left-handed Those who are in dispute or are very likely to dispute because of the brain injury.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Detectability of diffuse axonal injury with 123I-Iomazenil SPECT
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath